C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s173. https://doi.org/10.25251/skin.7.supp.173